Agios Pharmaceuticals
AGIO
AGIO
163 hedge funds and large institutions have $1.36B invested in Agios Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 60 increasing their positions, 58 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding
Funds holding: →
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
16% less capital invested
Capital invested by funds: $1.62B → $1.36B (-$266M)
44% less call options, than puts
Call options by funds: $4.85M | Put options by funds: $8.67M
Holders
163
Holding in Top 10
–
Calls
$4.85M
Puts
$8.67M
Top Buyers
| 1 | +$16.3M | |
| 2 | +$10.1M | |
| 3 | +$9.89M | |
| 4 |
Nordea Investment Management
Stockholm,
Sweden
|
+$7.08M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
+$5.98M |
Top Sellers
| 1 | -$37.6M | |
| 2 | -$19.2M | |
| 3 | -$13.8M | |
| 4 |
RSCM
Rock Springs Capital Management
Baltimore,
Maryland
|
-$7.69M |
| 5 |
SCM
Suvretta Capital Management
New York
|
-$5.32M |